Cite
HARVARD Citation
Linker, R. et al. (2016). Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study. Neurology and therapy. 5 (2), pp. 193-201. [Online].